The African Journal of Pharmaceutical Research and Development (AJOPRED; ISSN: 0794-800X) is the official scientific journal of the Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka. AJOPRED is dedicated to publish high quality and innovative research papers, review articles, case reports and short communications in all areas of Pharmaceutical Sciences, Biomedical Research and allied sciences including, but not limited to, Pharmaceutical Technology, Pharmaceutical Product Development, Pharmaceutics, Biopharmaceutics, Pharmacognosy and Phytochemistry, Herbal and Natural product Research, Pharmaceutical Microbiology, Pharmacotherapy, Clinical Pharmacy and Hospital Pharmacy, Pharmacology& Toxicology, Pharmacodynamics, Pharmacokinetics, Clinical Pharmacology, Neuro- and Behavioural Pharmacology, Immunopharmacology, Nutraceuticals, Pharmacogenetics, Pharmacogenomics, Pharmacoepidemiology, Toxicology, Posology, Novel Drug Delivery, Pharmaceutical/Medicinal Chemistry, Formulation Science, Cosmetic Product Development, Pharmaceutical Analysis, Quality Assurance and Quality Control, Pharmacy Practice, Clinical and Hospital Pharmacy, Bioinformatics and Pharmacy Informatics, Pharmaceutical Biotechnology, Chemotherapy, Biochemistry and Biomedical Sciences, Veterinary Pharmacy, Environmental Toxicology, Drug safety testing, Drug legislation, Forensic and Regulatory affairs, etc.,
The journal is a quality controlled, peer reviewed, and open access international journal. AJOPRED encourages and publishes translational researches of scientists involved in the promotion of research and development in the Pharmaceutical and related Biomedical Sciences in Africa and beyond. All manuscripts will be subjected to rapid peer review by at least two independent referees. Those of high quality, after review, will be published
Please read the following instructions carefully or any query, contact us at: at ajopred.com or send an email to: firstname.lastname@example.org
The authors are requested to prepare their manuscripts as per the instructions/specifications given below. It should be noted that the review process and acceptance of manuscript depend on the quality, significance, and relevance of the work presented in the manuscript. Adhering to instruction to authors as presented below will hasten the peer and editorial review process. Therefore, authors are strongly encouraged to read these instructions carefully before preparing/submitting their manuscript for publication.
Submission of a manuscript to African Journal of Pharmaceutical Research and Development for publication implies that the same work has not been previously published nor under consideration for publication in another journal. Authors, in their cover note to the editor, have to clearly state whether the manuscript shall be considered as a Research Paper, Case Report or Short Communication or Letter to the and also confirm that the manuscript has not been submitted to any other Journal forpublication. Review Article should be by invitation only. Authors publishing results from in vivo experiments involving animals or humans should clearly indicate, by including a statement to this effect, whether due permission for conduction of such experiments was obtained, from the relevantethics committees, in the Materials and Methods section.
· Full length research articles
· Review articles
· Short communications
Submission of manuscript should be with the understanding that the manuscript has not been previously published or concurrently under consideration for publication in any other journal. A statement to this effect should be clearly stated in the forwarding letter to the editor of AJOPRED.
Manuscript should be submitted online at ajopred.com or sent by email to: email@example.com
The preferred format of all manuscripts is MS Word. Figures, images (in JPEG, TIFF or SFC format), illustrations and tables should be inserted in the manuscript (or alternatively use “Figure 1 or Table 1 or numbers to indicate the position) at the positions they should appear when finally published in the final version of the manuscript. Manuscripts must be typed, double- spacedon A4 (8.5″ × 11″) paper size with 1 inch margins and should be arranged in the following order: Title, Abstract, Keywords, Introduction, Experimental (or Materials and Methods), Results, Discussion (or Results and Discussion), Conclusion, Acknowledgement (if any), References.
1. Title Page
It should have Title, Name(s) of author(s) and their affiliations i.e. postal address, phone no., corresponding author’s email address(es). The title must be as brief as possible, comprehensive and descriptive. Each author must provide their full name (surname first followed by name initials e.g. Ofokansi KC, Attama AA …) followed by their address in normal face lower case. The Corresponding Author of the manuscript must be marked with an asterisk. In addition the corresponding author must include telephone (mobile number, for ready contact during peer review) and e-mail address at the bottom left corner of the title page. If any of the coauthors are from different organizations, their addresses too should be mentioned and indicated using numbers after their names.
The abstract should start on a new page after the title page and should present the reason for the study, the methodology, the mainfindings, and principal conclusions and should not be more than 300 words. All the three categories, Review Articles, Research papers and Short Communications should have an Abstract.
Keywords (3-6) are to be provided by the authors separated by a ‘coma”.
The introduction section should represent the scope, objective and novelty of the research work.This should start on a new page and should clearly indicate the objective(s) of thestudy. It should provide an adequate background, avoiding a detailed literature survey or a summary of the results
5. Materials and Methods
This section should contain information about the materials and the methods adopted to carry out the research work like animals, chemicals and animal ethical committee permission, software used and procedures followed etc. Chemical compounds should be named according to IUPAC or Chemical Abstracts. The units and dimensions should be expressed according to the metric system and SI units. It should include concise details on the methodology adopted, sufficient to repeat the experiment. Extracts and/or fractions tested for in vitro or in vivo biologicalactivities should be chemically defined, at least by means of the results of preliminary phytochemical screening. Complete formulation details of all crude drug mixtures and extracts should be mentioned. The plant name should be fully mentioned when cited first, and the authors are asked to add the details regarding its identification, voucher herbarium specimen number and name of the herbariuminstitution where it has been deposited.
Abbreviations should be preceded by words for which they stand at the first appearance in the manuscript. The statistical method and the level of significance chosen should be clearly stated.
All results presented in tabular or graphical form shall be described in this section.
Figures (photographs, drawings, diagrams and charts) should be clear, easily legible and cited consecutively using Arabic numerals in the text(Figure 1, Figure 2…etc.). Legends should contain sufficient detail to permit figure interpretation without reference to the text.Tables must be concise and cited consecutively using Arabic numerals in the text (Table 1, Table 2…etc.). Each table should be typed on a separate sheet. The title of the table should clearly indicate the nature of the contents and sufficient detail should be included in the footnote to facilitate interpretation without reference to the text. Use horizontal rules only. All Tables and figures must have a title and a legend to make them self-explanatory and they should be numbered.
Identify statistical significance using superscripts (* and **) following the data (*P < 0.05, **P < 0.01).
7. Discussion and Conclusion
Discussion and conclusions should contain a critical review of the results of the study with the supportof relevant literature. It can end with brief conclusions.
It should contain the information regarding any research grant support or the assistance of colleagues.
References should be referred to by Arabic numeralsenclosed in square brackets e.g. , [1,3,5] or [1-4]) and should benumbered consecutively in the order in which they are mentioned. Use complete name of the journal for non-indexed journals. Information from manuscripts submitted but not accepted shouldbe cited in the text as “unpublished works” with written permission from the source.Avoid citing a “personal communication” unless it provides essential information not available from apublic source, in which case the name of the person and date of communication should be cited inparentheses in the text.
Journals: Author (last name) AB (initials), Author BB, Title of Article, Journal name, volume, year, page numbers.
Books: Author AB, Author BB, Author CC, Title of Book, Ed, Vol, Publisher, City, year, page
Contribution in a book:
Author AB, Author BB, …Biopolymer Cross-links: Strategies for Improving Drug Release and Delivery, In: Adikwu MU and Esimone CO Eds. Biopolymers in Drug Delivery: Recent Advances and Challenges, Bentham Publishers, USA, year, page numbers.
The editorial board reserves the right to condense or make necessary changes in the length of manuscript.
African Journal of Pharmaceutical Research & Development (AJOPRED) is a peer-reviewed, open access journal and is supported by Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, as well as article processing charges paid by authors and contributors to the journal. There are no printing, subscription or membership charges for any author. For every accepted manuscript, the corresponding author will have to pay a nominal cost of 120 USD (United States Dollars) irrespective of the number of pages. Authors within Nigeria will have to pay a nominal cost
N15,000.00 for an accepted manuscript irrespective of the number of pages. This nominal cost represents sustainability cost of manuscript processing, maintenance of published works insecured databases, website maintenance and upgrading, and to meet various overhead expenses.
Proofs will be sent to the corresponding author. One corrected proof, together with the original edited manuscript should be returned within one week of receipt either by surface mail or email as attachment.
Abstracting and Indexing
AJOPRED is currently been considered for abstracting and indexing by various major international organizations.
Frequency of Publication
For now, each volume of AJOPRED will be published in three issues per year. There are plans to increase the frequency in due course. Evaluation of submitted manuscript will be rapid.
The submission of a manuscript by authors implies that they automatically agree to assign an exclusive copyright to the African Journal of Pharmaceutical Research & Development if the manuscript is accepted for publication. The work should not be published elsewhere in any form without the written permission of the African Journal of Pharmaceutical Research & Development. All rights of the articles published in the African Journal of Pharmaceutical Research & Development are reserved. No part of this publication may be reproduced, translated or transmitted in any form or by any means (electronic, mechanical or otherwise) without permission from the African Journal of Pharmaceutical Research & Development.
Human experiments should be performed only in accordance with the ethical standards provided by the responsible committee of the institution and in accordance with the Declaration of Helsinki (as revised in Edinburgh 2000), available at http://www.wma.net/e/policy/b3.htm. All investigations on human subjects must include a statement that the subject gave an informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Animal experiments should be in accordance with the instructions for the care and use provided by the institution at which the research was carried out.
All authors should have participated sufficiently in the work to take public responsibility for the content.
Inquiries may be directed to:
The Managing Editor,
African Journal of Pharmaceutical Research and Development,
C/o Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka
Nsukka 410001, Enugu State, NIGERIA